Equities

Jinyao Pharmaceutical Co Ltd

600488:SHH

Jinyao Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)3.78
  • Today's Change0.02 / 0.53%
  • Shares traded5.07m
  • 1 Year change-24.70%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments703609207
Total Receivables, Net609536629
Total Inventory7261,158976
Prepaid expenses541642
Other current assets, total164229
Total current assets2,1082,3601,883
Property, plant & equipment, net3,0843,1943,378
Goodwill, net--00
Intangibles, net472428342
Long term investments164307361
Note receivable - long term------
Other long term assets273319348
Total assets6,1426,6516,345
LIABILITIES
Accounts payable681627505
Accrued expenses1578451
Notes payable/short-term debt4921,003840
Current portion long-term debt/capital leases404295421
Other current liabilities, total205271206
Total current liabilities1,9402,2802,024
Total long term debt277459368
Total debt1,1741,7571,629
Deferred income tax183948
Minority interest800781824
Other liabilities, total15411990
Total liabilities3,1893,6783,352
SHAREHOLDERS EQUITY
Common stock1,0941,0961,100
Additional paid-in capital322327335
Retained earnings (accumulated deficit)1,4951,3911,369
Treasury stock - common(4.73)(10)(19)
Unrealized gain (loss)47169211
Other equity, total(0.35)(0.83)(3.34)
Total equity2,9542,9732,993
Total liabilities & shareholders' equity6,1426,6516,345
Total common shares outstanding1,0921,0921,092
Treasury shares - common primary issue2.054.488.16
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.